Skip to content

The Effect of Berry Extract on Helicobacter Pylori Eradication

The Adjuvant Effect of Berry Extract on Triple Therapy for Helicobacter Pylori Eradication

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01045408
Enrollment
120
Registered
2010-01-11
Start date
2009-01-31
Completion date
2010-06-30
Last updated
2010-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Increase the Eradication Rate of Helicobacter Pylori

Keywords

Helicobacter pylori, Berry extract, Triple therapy

Brief summary

Helicobacter pylori (HP) is the major risk factors of gastritis, gastric ulcers, duodenal ulcers, mucosa associated lymphoid tissue lymphoma and gastric cancer. Helicobacter pylori are found in 70-90% of the population in developing countries and in 25-50% of developed countries.

Detailed description

One-week of triple therapy composed of a proton pump inhibitor plus two antibiotics is currently regarded as the gold standard for HP eradication. However, the eradication rate continues to be disappointing. Poor patient compliance and bacterial resistance are the main factors contributing to treatment failure. Therefore, it is urgently necessary to develop a non-antibiotic alternative therapy to increase the eradication rates of Helicobacter pylori. Some literatures reported that cranberry may inhibit Helicobacter pylori adhesion to the human gastric mucus and may reduce Helicobacter pylori infection in adults. The aims of his experiment were to explore the impact of berry extract on triple therapy for Helicobacter pylori eradication.

Interventions

DIETARY_SUPPLEMENTBerry extract

Berry extract for weeks

Sponsors

Shin Kong Wu Ho-Su Memorial Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients older than 18

Exclusion criteria

* Pregnancy or breastfeeding * Use of antibiotics 2 weeks prior to inclusion * Previous eradication treatment

Design outcomes

Primary

MeasureTime frame
Eradication rate4 weeks after Eradication of Helicobacter pylori

Countries

Taiwan

Contacts

Primary ContactChian-Sem Chua, MD
886-2-28332211

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026